Germany Insulin Drugs And Delivery Devices Market Share

Statistics for the 2023 & 2024 Germany Insulin Drugs And Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. Germany Insulin Drugs And Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Germany Insulin Drugs And Delivery Devices Industry

The Germany Insulin Drugs and Delivery Devices Market is moderately consolidated, with few significant and generic players. Mergers and acquisitions between the players recently have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

Germany Insulin Drugs And Delivery Devices Market Leaders

  1. Medtronic

  2. Ypsomed

  3. Novo Nordisk A/S

  4. Eli Lilly and Company

  5. Sanofi Aventis

*Disclaimer: Major Players sorted in no particular order

Germany Insulin Drugs And Delivery Devices Market Concentration

Germany Insulin Drugs And Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)